Lung function and exacerbations in patients with COPD escalated to triple therapy: The RETRIEVE real-world study.

Tryfon, Stavros; Papadopoulou, Efthymia; Bertoli, Maria; Exarchos, Konstantinos; Ginis, Alexandros; Kostikas, Konstantinos

Tryfon, Stavros; Papadopoulou, Efthymia; Bertoli, Maria; Exarchos, Konstantinos; Ginis, Alexandros; Kostikas, Konstantinos.

Affiliation

Tryfon S; Pulmonology Department, General Hospital of Thessaloniki "G. Papanikolaou", Thessaloniki, Greece.
Papadopoulou E; Pulmonology Department, General Hospital of Thessaloniki "G. Papanikolaou", Thessaloniki, Greece.
Bertoli M; Medical Department, ELPEN Pharmaceutical Co. Inc., Pikermi, Greece.
Exarchos K; Respiratory Medicine Department, University of Ioannina School of Medicine, Ioannina, Greece.
Ginis A; Medical Department, ELPEN Pharmaceutical Co. Inc., Pikermi, Greece.
Kostikas K; Respiratory Medicine Department, University of Ioannina School of Medicine, Ioannina, Greece.

Respirology ; 28(12): 1166-1169, 2023 Dec.

Article de En | MEDLINE | ID: mdl-37879756

Sujet(s)
Mots clés

COPD exacerbations; FEV1; chronic obstructive pulmonary disease; open triple therapy; salmeterol-fluticasone fixed-dose combination

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Bronchodilatateurs / Broncho-pneumopathie chronique obstructive Limites: Humans Langue: En Journal: Respirology Année: 2023 Type de document: Article Pays d'affiliation: Grèce Pays de publication: Australie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google